Mostrar el registro sencillo del ítem

Características medio-ambientales, de actividad, cronicidad y calidad de vida de los pacientes con lupus eritematoso sistémico atendidos en dos hospitales universitarios de Bogotá

dc.contributor.advisorLondoño Patiño, John Darío
dc.contributor.advisorOvalle Oñate, Rafael
dc.contributor.advisorDe Zubiría, Alberto
dc.contributor.advisorBello Gualtero, Juan Manuel
dc.contributor.advisorJaimes Fernández, Diego Alejandro
dc.contributor.authorSalazar Ponce, Rosa Elena
dc.contributor.authorMurcia Pinilla, Lina María
dc.contributor.authorDe la Cruz Nocera, Giovanni
dc.date.accessioned2012-08-15T17:24:25Z
dc.date.available2012-08-15T17:24:25Z
dc.date.created2011
dc.date.issued2012-08-15
dc.identifier.citationPons-Estel GJ, Alarcon GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 2010; 39:257-68.
dc.identifier.citationTikly M, Navarra SV. Lupus in the developing world is it any different? Best Pract Res Clin Rheumatol. 2008; 22:643-55.
dc.identifier.citationRahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008; 358:929- 39.
dc.identifier.citationPetri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2002; 16:847-58.
dc.identifier.citationMcCarty DJ, Manzi S, Medsger TA, Jr., Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum. 1995; 38:1260-70.
dc.identifier.citationMcAlindon T. Update on the epidemiology of systemic lupus erythematosus: new spins on old ideas. Curr Opin Rheumatol. 2000; 12:104-12.
dc.identifier.citationSimard JF, Costenbader KH. What can epidemiology tell us about systemic lupus erythematosus? Int J Clin Pract. 2007; 61:1170-80.
dc.identifier.citationJimenez S, Cervera R, Font J, Ingelmo M. The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol. 2003; 25:3-12.
dc.identifier.citationIsenberg D, Bacon P, Bombardier C, Gladman D, Goldsmith CH, Kalunian K, et al. Criteria for assessing disease activity in systemic lupus erythematosus. J Rheumatol. 1989;16:1395-6
dc.identifier.citationChang E, Abrahamowicz M, Ferland D, Fortin PR. Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians. J Clin Epidemiol. 2002; 55:488- 97.
dc.identifier.citationGladman D, Urowitz M, Kagal A, Hallet D. Accurately describing changes in disease activity in systemic lupus erythematosus. J Rheum. 2000; 27:377-9.
dc.identifier.citationGriffiths B, Mosca M, Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol. 2005; 19:685-708.
dc.identifier.citationYee CS, McElhone K, Teh LS, Gordon C. Assessment of disease activity and quality of life in systemic lupus erythematosus - New aspects. Best Pract Res Clin Rheumatol. 2009; 23:457-67.
dc.identifier.citationMosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R, et al. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis. 2010; 69:1269-74.
dc.identifier.citationAlarcon GS, Calvo-Alen J, McGwin G, Jr., Uribe AG, Toloza SM, Roseman JM, et al. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis. 2006; 65:1168-74.
dc.identifier.citationFernandez M, Calvo-Alen J, Alarcon GS, Roseman JM, Bastian HM, Fessler BJ, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women. Arthritis Rheum. 2005; 52:1655-64.
dc.identifier.citationGordon C, Sutcliffe N, Skan J, Stoll T, Isenberg DA. Definition and treatment of lupus flares measured by the BILAG index. Rheumatology. 2003; 42:1372-9.
dc.identifier.citationBombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992; 35:630-40.
dc.identifier.citation. Bencivelli W, Vitali C, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, Bombardieri S. Disease activity in systemic lupus erythematosus: report of the Consen- sus Study Group of the European Workshop for Rheumatology Research. III. Development of a computerised clinical chart and its application to the comparison of different indices of disease activity. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol. 1992; 10:549-54.
dc.identifier.citationGladman D, Ibanez D, Urowitz M. Systemic lupus erythematosus activity index 2000. J Rheumatol. 2002; 29:288-91.
dc.identifier.citationLiang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1989; 32:1107-18.
dc.identifier.citationGladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996; 39:363-9.
dc.identifier.citationGladman DD, Urowitz MB. The SLICC/ACR damage index: progress report and experience in the field. Lupus. 1999; 8:632-7.
dc.identifier.citationRahman P, Gladman DD, Urowitz MB, Hallett D, Tam LS. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus. 2001; 10:93-96.
dc.identifier.citation. Ware JE, Kosinski M. Interpreting SF-36 summary health measures: a response.Qual Life Res. 2001; 10:405-13
dc.identifier.citationAlmehed K, Carlsten H, Forsblad-d'Elia H. Health-related quality of life in systemic lupus erythematosus and its association with disease and work disability. Scand J Rheumatol. 2010; 39:58-62.
dc.identifier.citationPons-Estel BA, Catoggio LJ, Cardiel MH, Soriano ER, Gentiletti S, Villa AR, et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics". Medicine (Baltimore). 2004; 83:1-17.
dc.identifier.citationAlarcón GS, Friedman AW, Straaton KV, Moulds JM, Lisse J, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture. Lupus. 1999; 8:197-209.
dc.identifier.citationIsenberg DA, Allen E, Farewell V, D'Cruz D, Alarcón GS, Aranow C, et al. An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA. Ann Rheum Dis. 2011; 70:54-9.
dc.identifier.citationPope J. The revised BILAG Index with numerical scoring in systemic lupus erythematosus: added value with some limitations.Rheumatology (Oxford). 2010; 49:1616-7.
dc.identifier.citationYee CS, Cresswell L, Farewell V, Rahman A, Teh LS, Griffiths B, et al. Numerical scoring for the BILAG-2004 index. Rheumatology (Oxford). 2010; 49:1665-9
dc.identifier.citationFurie RA, Petri MA, Wallace DJ, Ginzler EM, Merrill JT, Stohl W, et al. Novel evidencebased systemic lupus erythematosus responder index. Arthritis Rheum. 2009; 61:1143- 51.
dc.identifier.citationPetri M. Review of classification criteria for systemic lupus erythematosus. Rheum Dis Clin North Am. 2005; 31:245-54
dc.identifier.citationRuiz O, Londoño J; Velez P; Ortiz I; Motta L; Valle-Oñate R. Descripcion de una cohorte de pacientes con Lupus Eritematoso Sistemico (LES) en un Hospital de BogotaColombia. Rev Colomb Rumatol. 2003; 10:266-76.
dc.identifier.citationMolina JF, Drenkard C, Molina J, Cardiel MH, Uribe O, Anaya JM, et al. Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine (Baltimore). 1996; 75:124-30.
dc.identifier.citationManger K, Manger B, Repp R, Geisselbrecht M, Geiger A, Pfahlberg A, et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis. 2002; 61:1065-70
dc.identifier.citationGarcia MA, Marcos JC, Marcos AI, Pons-Estel BA, Wojdyla D, Arturi A, et al. Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients. Lupus. 2005; 14:938-46
dc.identifier.citationPinto L VC, Márquez Y. Subgrupos de Lupus Eritematoso Sistémico: influencia de la edad de inicio, la raza, el sexo y el perfil de anticuerpos en las manifestaciones clínicas de la enfermedad. Rev Col Reumatol. 2008; 15:291-8
dc.identifier.citationHsu CY, Pu C, Sewell KL. Systemic lupus erythematosus as a cause of failure to thrive in older people. J Am Geriatr Soc.1996; 44:337-8.
dc.identifier.citationSchiavon LL, Carvalho-Filho RJ, Narciso-Schiavon JL, Lanzoni VP, Ferraz ML, Silva AE. Late-onset systemic lupus erythematosus-associated liver disease. Rheumatol Int. 2010 Apr 8. [Epub ahead of print]
dc.identifier.citationKoh ET, Boey ML. Late onset lupus: a clinical and immunological study in a predominantly Chinese population. J Rheumatol. 1994; 21:1463-7.
dc.identifier.citationGonzález LA, Ramírez LA. Lupus eritematoso sistémico de inicio tardío. Rev Colomb Reumatol. 2008; 15:168-85.
dc.identifier.citationGaviria L, Rodelo J , Uribe O , Vásquez G, Ramírez L Características clínicas y serológicas de los pacientes con LES de inicio tardío en una población colombiana. Rev Colomb Reumatol. 2007; 14: 23-31
dc.identifier.citationBaer AN, Maynard JW, Shaikh F, Magder LS, Petri M. Secondary Sjogren's syndrome in systemic lupus erythematosus defines a distinct disease subset. J Rheumatol. 2010; 37:1143-9.
dc.identifier.citationToloza SM, Jolly M, Alarcón GS. Quality-of-life measurements in multiethnic patients with systemic lupus erythematosus: cross-cultural issues. Curr Rheumatol Rep. 2010; 12:237-49
dc.identifier.citationDrenkard C, Alarcon-Segovia D. The new prognosis of systemic lupus erythematosus: treatment-free remission and decreased mortality and morbidity. Isr Med Assoc J. 2000; 2:382-7.
dc.identifier.citationDuran S, Gonzalez LA, Alarcon GS. Damage, accelerated atherosclerosis, and mortality in patients with systemic lupus erythematosus: lessons from LUMINA, a multiethnic US cohort. J Clin Rheumatol. 2007; 13:350-3
dc.identifier.citationLalani S, Pope J, de Leon F, Peschken C; Members of CaNIOS/1000 Faces of Lupus. Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study. J Rheumatol. 2010 ;37:38-44
dc.identifier.citationStoll T, Sutcliffe N, Mach J, Klaghofer R, Isenberg DA. Analysis of the relationship between the disease activity and damage in patients with systemic lupus erythematosus a 5 year prospective study. Rheumatology. 2004; 43:1039-44
dc.identifier.citationStoll T, Seifert B, Isenberg D. ACR/SLICC damage index is a useful predictor of severe outcome in SLE patients and an indicator of morbidity in different ethnic groups. Brit J Rheumatol. 1996; 35:248-54.
dc.identifier.citationChambers SA, Allen E, Rahman A, Isenberg D. Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. Rheumatology (Oxford). 2009; 48:673-5
dc.identifier.citationAlarcón GS, Roseman JM, McGwin G Jr, Uribe A, Bastian HM, Fessler BJ, Baethge BA, Friedman AW, Reveille JD; LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage Rheumatology (Oxford). 2004; 43:202-5.
dc.identifier.citationGilboe IM, Kvien TK, Husby G. Disease course in systemic lupus erythematosus: changes in health status, disease activity, J Rheumatol. 2001; 28:266-74
dc.identifier.citationYazdany J, Yelin E. Health-Related Quality of Life and Employment Among Persons with Systemic Lupus Erythematosus . Rheum Dis Clin North Am. 2010; 36: 15–32.
dc.identifier.citationAlarcón GS, McGwin G Jr, Uribe A, Friedman AW, Roseman JM, Fessler BJ, et al. Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum. 2004; 51:465-74.
dc.identifier.urihttp://hdl.handle.net/10818/3418
dc.description159 Páginas.
dc.description.abstractObjetivo. Características de LES en Colombianos. Métodos. Corte transversal. Resultados. 109 pacientes; Mujeres 91.7%; Edad media diagnóstico 30,6±12,5 años. Artritis (61,5%), alopecia (59,6%) pérdida de peso (54,1%), proteinuria (34,9 %), xeroftalmia (33 %), xerostomía (28,4 %), trombocitopenia (27,5%) y S. Sjögren (21,1%) mas frecuentes. BILAG: Leve (45,9%), moderada (3,5%) y severa ( 27,5%). SLICC/ACR: 50 (45,8%). SF36: ≤50 ( 83,5% y 74,3%) y ≥51 (16,5% y 30,2%) en dominios salud física y salud mental. Correlación moderada e inversa: Estrato socioeconómico (-0,41), nivel educativo (-0,36) y daño orgánico; Correlación débil: SF 36 componente físico (-0,21) y daño orgánico. Conclusiones: Hay alta frecuencia de S. de Sjögren. Hay correlación significativa con nivel educativo, estrato socioeconómico y peor función física con daño orgánico.es_CO
dc.language.isospaes_CO
dc.publisherUniversidad de La Sabana
dc.sourceUniversidad de La Sabana
dc.sourceIntellectum Repositorio Universidad de La Sabana
dc.subjectLupus eritematoso sistémico-Investigacioneses_CO
dc.subjectLupus eritematoso sistémico-Epidemiología-Investigacioneses_CO
dc.subjectLupus eritematoso sistémico-Patología-Investigacioneses_CO
dc.subjectLupus eritematoso sistémico-Clases sociales-Investigacioneses_CO
dc.titleCaracterísticas medio-ambientales, de actividad, cronicidad y calidad de vida de los pacientes con lupus eritematoso sistémico atendidos en dos hospitales universitarios de Bogotáes_CO
dc.typebachelorThesis
dc.publisher.programEspecialización en Medicina Interna
dc.publisher.departmentFacultad de Medicina
dc.identifier.local152672
dc.identifier.localTE00273
dc.type.localTesis de especialización
dc.type.hasVersionpublishedVersion
dc.rights.accessRightsopenAccess
dc.creator.degreeEspecialista en Medicina Interna


Ficheros en el ítem

Thumbnail
Nombre:
Rosa Elena Salazar Ponce_152672.pdf
Tamaño:
6.871Mb
Formato:
PDF
Descripción:
Ver documento en PDF
Ver/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem